๐Ÿ”Ž Trials Near Me

Home โ€บ Mesothelioma

Mesothelioma clinical trials recruiting in the U.S.

45 studies for Mesothelioma are recruiting participants at sites across the United States.

Mesothelioma is a tumor of mesothelium, a tissue that lines lungs and other organs. Most people who get it have inhaled asbestos. Read the symptoms.

Cities with the most studies

By state

Recently updated studies

SW-682 in Advanced Solid Tumors

RecruitingPhase 1
Ages 18 and older ยท All sexes ยท Updated Oct 2, 2026 ยท NCT06251310

Evaluation of Cell Changes in Blood and Tissue in Cancers of the Lung, Esophagus and Lung Lining

RecruitingObservational study
Ages 2 to 120 ยท All sexes ยท Updated Oct 2, 2026 ยท NCT00242723

Tissue Procurement and Natural History Study of Patients With Malignant Mesothelioma

RecruitingObservational study
Ages 2 to 100 ยท All sexes ยท Updated Oct 2, 2026 ยท NCT01950572

Anti-Mesothelin TNaive/SCM hYP218 (TNhYP218) CAR T Cells in Participants With Mesothelin-Expressing Solid Tumors Including Mesothelioma

RecruitingPhase 1
Ages 18 to 120 ยท All sexes ยท Updated Oct 2, 2026 ยท NCT06885697

Long Term Follow-Up of Patients With Mesothelioma and Individuals With Germline Mutations in BAP1

RecruitingObservational study
Ages 2 to 120 ยท All sexes ยท Updated Oct 2, 2026 ยท NCT03830229

Neoadjuvant Durvalumab and Tremelimumab With and Without Chemotherapy for Mesothelioma

RecruitingPhase 1/2Healthy volunteers welcome
Ages 18 and older ยท All sexes ยท Updated Oct 2, 2026 ยท NCT05932199

A Study of IDE892 as Monotherapy and Combination in MTAP-deleted Advanced Solid Tumors

RecruitingPhase 1
Ages 18 and older ยท All sexes ยท Updated Sep 28, 2026 ยท NCT07277413

Solid Tumor Analysis for HLA Loss of Heterozygosity (LOH) and Apheresis for CAR T- Cell Manufacturing

RecruitingObservational study
Ages 18 and older ยท All sexes ยท Updated Sep 25, 2026 ยท NCT04981119

Using E-Nose Technology to Measure Response to Treatment in People With Malignant Pleural Mesothelioma

Recruiting
Ages 30 to 85 ยท All sexes ยท Updated Sep 24, 2026 ยท NCT06037941

A Study of Additional Chemotherapy After Surgery for People With Malignant Peritoneal Mesothelioma

RecruitingPhase 2
Ages 18 and older ยท All sexes ยท Updated Sep 24, 2026 ยท NCT06057935

A Study of SHY-ONC6, a Novel Proteasome Inhibitor, in Adults With Advanced or Metastatic Solid Tumors

RecruitingPhase 1
Ages 18 and older ยท All sexes ยท Updated Sep 18, 2026 ยท NCT07705334

Study of ISM6331 in Participants With Advanced/Metastatic Mesothelioma or Other Advanced Solid Tumors

RecruitingPhase 1/2
Ages 18 and older ยท All sexes ยท Updated Sep 16, 2026 ยท NCT06566079

TT-4 and TT-10 as Single Agents and in Combination in Subjects With Advanced Selected Solid Tumors and Pleural Mesothelioma

RecruitingPhase 1/2
Ages 18 and older ยท All sexes ยท Updated Sep 15, 2026 ยท NCT04969315

Safety and Tolerability of TNG462 in Patients With MTAP-deleted Solid Tumors

RecruitingPhase 1/2
Ages 18 and older ยท All sexes ยท Updated Sep 8, 2026 ยท NCT05732831

Phase 1 Study of MRTX1719 in Solid Tumors With MTAP Deletion

RecruitingPhase 1
Ages 18 and older ยท All sexes ยท Updated Sep 2, 2026 ยท NCT05245500

A Study of Tulmimetostat DZR123 (CPI-0209) in Patients With Advanced Solid Tumors and Lymphomas

RecruitingPhase 1/2
Ages 18 and older ยท All sexes ยท Updated Aug 19, 2026 ยท NCT04104776

Fast TILs to Treat Metastatic Cancer Patients With Pleural Disease

RecruitingPhase 1
Ages 18 to 79 ยท All sexes ยท Updated Aug 4, 2026 ยท NCT07192900

Rinatabart Sesutecan (Rina-S, PRO1184, GEN1184) for Advanced Solid Tumors (GCT1184-01/ PRO1184-001)

RecruitingPhase 1/2
Ages 18 and older ยท All sexes ยท Updated Aug 4, 2026 ยท NCT05579366

Lead-212 PSV359 Therapy for Patients With Solid Tumors

RecruitingPhase 1/2
Ages 18 to 90 ยท All sexes ยท Updated Jul 6, 2026 ยท NCT06710756

Integrated Cancer Repository for Cancer Research

RecruitingObservational studyHealthy volunteers welcome
Ages 19 to 110 ยท All sexes ยท Updated Jun 29, 2026 ยท NCT02012699

SynKIR-110 for Mesothelin Expressing Ovarian Cancer, Cholangiocarcinoma or Mesothelioma

RecruitingPhase 1
Ages 18 and older ยท All sexes ยท Updated Jun 24, 2026 ยท NCT05568680

CT-95 in Advanced Cancers Associated With Mesothelin Expression

RecruitingPhase 1
Ages 18 and older ยท All sexes ยท Updated Jun 12, 2026 ยท NCT06756035

From ClinicalTrials.gov, data retrieved Oct 3, 2026. Each study sets its own eligibility; the study team decides who can join.